These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 10523062)

  • 21. Anxiety and depression: individual entities or two sides of the same coin?
    Nutt D
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():19-24. PubMed ID: 24930685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.
    Bourin M
    Hum Psychopharmacol; 2003 Apr; 18(3):185-90. PubMed ID: 12672169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.
    Bradley AJ; Lenox-Smith AJ
    J Psychopharmacol; 2013 Aug; 27(8):740-58. PubMed ID: 23832963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.
    Hood SD; Hince DA; Davies SJ; Argyropoulos S; Robinson H; Potokar J; Nutt DJ
    Psychopharmacology (Berl); 2010 Feb; 208(2):223-32. PubMed ID: 19936713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
    Murphy TK; Bengtson MA; Tan JY; Carbonell E; Levin GM
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S47-63. PubMed ID: 11110019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
    Blier P; Szabo ST
    J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
    Benkert O; Wetzel H; Szegedi A
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
    [No Abstract]   [Full Text] [Related]  

  • 28. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients.
    Worthington JJ; Kinrys G; Wygant LE; Pollack MH
    Int Clin Psychopharmacol; 2005 Jan; 20(1):9-11. PubMed ID: 15602109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
    Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new antidepressants. Selective serotonin reuptake inhibitors.
    Labellarte MJ; Walkup JT; Riddle MA
    Pediatr Clin North Am; 1998 Oct; 45(5):1137-55, ix. PubMed ID: 9884679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitor exposure.
    Fitzgerald KT; Bronstein AC
    Top Companion Anim Med; 2013 Feb; 28(1):13-7. PubMed ID: 23796482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the quality of care for depressed patients with comorbid psychiatric disorders: a review.
    Dunner DL
    Clin Perform Qual Health Care; 1997; 5(1):11-5. PubMed ID: 10164994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Depression and anxiety. Broad spectrum SSRI to control both].
    MMW Fortschr Med; 2001 Sep; 143(35-36):55-6. PubMed ID: 11584534
    [No Abstract]   [Full Text] [Related]  

  • 36. [Selective serotonin reuptake inhibitor(SSRI)].
    Motohashi N
    Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting response: serotonin reuptake inhibition.
    Mendlewicz J
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 1():S17-20. PubMed ID: 10468324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective serotonin-reuptake inhibitors: an update.
    Masand PS; Gupta S
    Harv Rev Psychiatry; 1999; 7(2):69-84. PubMed ID: 10471245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in total medical costs across the SSRIs for the treatment of depression and anxiety.
    Sheehan DV; Eaddy MT; Shah MB; Mauch RP
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S354-61. PubMed ID: 16236017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.